Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01703702 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
A Phase 4 study, sponsored by Avid Radiopharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 641
- Enrollment target
NCT01703702: Completed Phase 4 study, sponsored by Avid Radiopharmaceuticals.
NCT01703702 is a Phase 4 study that has completed, run by Avid Radiopharmaceuticals. The registered enrollment target is 641 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (24% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01703702, a Phase 4 study, has completed, sponsored by Avid Radiopharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 641 participants
- Enrollment target
Study Summary
This study is designed to determine the effectiveness of florbetapir (18F) in changing patient management and to evaluate the association between scan status and cognitive decline.
Primary Outcome
Comparison of the percentage of patients who have a change in management from baseline to 3 months for patients who receive scan results immediately (intervention arm) and those who receive scan results 12 months later (control arm).
Interventions
- DRUG florbetapir (18F)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 641 participants |
| Start Date | 2012-10 |
| Est. Completion | 2015-04 |
| Phase | Phase 4 |
What the finished NCT01703702 record still lists
NCT01703702 is an interventional study that assigns participants to a tested intervention. The registered 641 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (24% higher).
The record links to 0 conditions, and to 1 intervention - of which florbetapir (18F) is the first listed.
NCT01703702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01703702 about?
NCT01703702 is a clinical study titled "Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline". This study is designed to determine the effectiveness of florbetapir (18F) in changing patient management and to evaluate the association between scan status and cognitive decline.
What is the current status of trial NCT01703702?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 641 participants. The study started on 2012-10. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01703702?
The interventions under investigation include: florbetapir (18F) (DRUG).
Who is sponsoring clinical trial NCT01703702?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01703702's enrollment target sits among peer trials
641 126th of 2000 higher than 1,874 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06319820 · 641 participants · Phase 3
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
- NCT06625060 · 641 participants · Phase 2
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
- NCT05204888 · 642 participants · NA
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia